Evidence map›Paper›PMID 33671718›Full record

ArticleAntibiotics (Basel, Switzerland)2021

Impact of Treating Asymptomatic Bacteriuria in Kidney Transplant Recipients: A Prospective Cohort Study.

Sara Fontserè, Carmen Infante-Domínguez, Alejandro Suárez-Benjumea, Marta Suñer-Poblet, Carmen González-Corvillo, Guillermo Martín-Gutiérrez, Gabriel Bernal, Jerónimo Pachón, María Eugenia Pachón-Ibáñez, Elisa Cordero

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Sara FontserèUnit of Infectious Diseases, Microbiology, and Preventive Medicine, Virgen del Rocío University Hospital of Seville, 41013 Seville, Spain.ORCID 0000-0002-1750-8156
Carmen Infante-DomínguezUnit of Infectious Diseases, Microbiology, and Preventive Medicine, Virgen del Rocío University Hospital of Seville, 41013 Seville, Spain.
Alejandro Suárez-BenjumeaUrology and Nephrology Unit, Virgen del Rocío University Hospital, 41013 Seville, Spain.
Marta Suñer-PobletUrology and Nephrology Unit, Virgen del Rocío University Hospital, 41013 Seville, Spain.
Carmen González-CorvilloUrology and Nephrology Unit, Virgen del Rocío University Hospital, 41013 Seville, Spain.
Guillermo Martín-GutiérrezUnit of Infectious Diseases, Microbiology, and Preventive Medicine, Virgen del Rocío University Hospital of Seville, 41013 Seville, Spain.
Gabriel BernalUnit of Infectious Diseases, Microbiology, and Preventive Medicine, Virgen del Rocío University Hospital of Seville, 41013 Seville, Spain.
Jerónimo PachónUnit of Infectious Diseases, Microbiology, and Preventive Medicine, Virgen del Rocío University Hospital of Seville, 41013 Seville, Spain.ORCID 0000-0002-8166-5308
María Eugenia Pachón-IbáñezUnit of Infectious Diseases, Microbiology, and Preventive Medicine, Virgen del Rocío University Hospital of Seville, 41013 Seville, Spain.ORCID 0000-0001-7969-8162
Elisa CorderoUnit of Infectious Diseases, Microbiology, and Preventive Medicine, Virgen del Rocío University Hospital of Seville, 41013 Seville, Spain.
Instituto de Biomedicina de Sevilla · ESHospital Universitario Virgen del Rocío · ES

Funding

- co- financed by European Development Regional Fund "A way to achieve Europe", Operative program Intelligent Growth 2014-2020. 2014-2020Instituto de Salud Carlos III PI17-01405Plan Nacional de I+D+i 2013-2016 and Instituto de Salud Carlos III, Subdirección General de Redes y Centros de Investigación Cooperativa, Ministerio de Ciencia, Innovación y Universidades, Spanish Network for Research in Infectious Diseases REIPI RD16/0016/0009
6 · The paper itself

Abstract

This study aims to define the epidemiologic, clinical, and microbiological features of asymptomatic bacteriuria (AB) and cystitis in kidney transplantation recipients (KTRs), and to determine the impact of antimicrobial therapy of AB and the risk factors of cystitis. We conducted a prospective observational study of AB and cystitis in KTRs from January to June 2017. One-hundred ninety seven KTRs were included: 175 (88.8%) with AB and 22 (11.2%) with cystitis. The most frequent etiologies were

Indexed as

asymptomatic bacteriuriacystitiskidney recipientsprospective observational cohorturinary tract infections

Identifiers

PMID33671718
PMCPMC7926960
OpenAlexW3130688936

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.